Louisiana Laws

Louisiana Laws & Regulations

The information contained on this website is provided for informational purposes only and should not be construed as legal advice on any matter. The Information constitutes general information of applicable administrative regulation and/or laws related to general topics in the arena of controlled substance misuse and abuse and may not reflect current legal developments and updates. Please refer to your state legislature for any potential changes. 

Menu

Louisiana Revised Statutes (LRS) Link

Louisiana Administrative Code (LAC) Link

Louisiana Pharmacy Law Book (2022)

Louisiana Advertising/Marketing Information

Louisiana Child Safety Information

  • LRS 14:93 – Cruelty to juveniles
  • LRS 14:403 – Abuse of children; reports; waiver of privilege
  • LRS 40:981 – Distribution to persons under age eighteen
  • LRS 40:1086.11 – Neonatal Abstinence Syndrome: Physician notification
  • LRS 40:1086.12 – Neonatal opiate withdrawal syndrome pilot project
  • LRS 40:2405.9 – Identification of minor or dependent children of an arrested person; guidelines and training

Louisiana Compounding Information

  • LRS 37:1224 Compounding and filling of prescriptions; absence of pharmacist
  • LRS 40:989.1 – Unlawful production, manufacture, distribution, or possession of hallucinogenic plants; exceptions
  • LRS 40:989.2 – Unlawful production, manufacturing, distribution, or possession of prohibited plant products; exceptions

Louisiana Coroner/Medical Examiner Information

Louisiana Drug Checking Information (Test Strips)

Louisiana Drug Cleanup Information (Methamphetamine & Fentanyl Labs)

  • LRS 9:3198.1 – Duties of governmental entities; contaminated property

Louisiana Drug Court Information

Louisiana Drug Free Workplace Information

Louisiana Drugged Driving Information

  • LRS 14:98 et seq – Driving Offenses: Operating a vehicle while intoxicated
  • LRS 15:578.1 – Pretrial diversion program for driving while intoxicated; criminal history records
  • LRS 15:1228.9 Impaired Driver Tracking System; purpose; procedure
  • LRS 32:661 – Operating a vehicle under the influence of alcoholic beverages or illegal substance or controlled dangerous substances; implied consent to chemical tests; administering of test and presumptions

Louisiana Drug Violations Information

  • LRS 40:967 – Prohibited acts – Schedule II; penalties
  • LRS 40:968 Prohibited acts–Schedule III; penalties
  • LRS 40:969 – Prohibited acts–Schedule IV; penalties
  • LRS 40:970 – Prohibited acts–Schedule V; penalties
  • LRS 40:971 – Prohibited acts; all schedules
  • LRS 40:971.1 – Prohibited acts; false representation
  • LRS 40:971.2 – Unlawfully prescribing, distributing, dispensing, or assisting in illegally obtaining controlled dangerous substances
  • LRS 40:971.3 – Misbranding or adulteration of drugs with intent to defraud or mislead
  • LRS 40:981 – Distribution to persons under age eighteen
  • LRS 40:981.2 – Soliciting minors to produce, manufacture, distribute, or dispense controlled dangerous substances
  • LRS 40:981.3 – Violation of Uniform Controlled Dangerous Substances Law; drug free zone
  • LRS 40:983 – Creation or operation of a clandestine laboratory for the unlawful manufacture of a controlled dangerous substance; definition; penalties
  • LRS 40:983.1 – Creation or operation of a clandestine laboratory for the unlawful manufacture of a controlled dangerous substance on or within one thousand feet of school property
  • LRS 40:1021 – Transactions in drug-related objects prohibited: definitions
  • LRS 40:1022 – Determination of drug paraphernalia
  • LRS 40:1023 – Prohibited Acts
  • LRS 40:1060.13 – Sale, distribution, or possession of legend drug without prescription or order prohibited; exceptions; penalties
  • LRS 40:1060.14 – Prescription requirements; penalties
  • LRS 40:1060.15 – Obtaining legend drugs by misrepresentation or fraud; penalties

Louisiana Electronic Prescribing Information

Louisiana First Responder Deflection Program(s) Information

  • NO STATE SPECIFIC INFORMATION IDENTIFIED

Louisiana 911 – Good Samaritan Information

  • LRS 14:403.10 Drug-related overdoses; medical assistance; immunity from prosecution
  • LRS 14:403.11 – Administration of opiate antagonists; immunity
  • LRS 40:978.1 – Naloxone; first responder; prescription; administration to third party; limitation of liability
  • LRS 40:978.2 – Naloxone; prescription; dispensing; administration by third party; limitation of liability

Louisiana Medical Marijuana, Recreational Marijuana & CBD Information

  • LAC 7- XLIX – Medical Marijuana
  • LRS 40:966 – Penalty for distribution or possession with intent to distribute narcotic drugs listed in Schedule I; possession of marijuana, synthetic cannabinoids, and heroin
  • LRS 40:1046 – Recommendation and dispensing of marijuana for therapeutic use; rules and regulations of the Louisiana Board of Pharmacy; production facility licensing; permitting by the Louisiana Department of Health
  • LRS 40:1046.1 – Dispensing of marijuana for therapeutic use to visiting qualifying patients
  • LRS 40:1168.1 – Findings and purpose
  • LRS 40:1168.2 – Definitions
  • LRS 40:1168.3 – Data system; components; reporting; design in collaboration with certain higher education institutions; public records exception
  • LRS 40:1168.4 – Protection of health information; limitations on data use
  • LSU Law – Cannabis Law in Louisiana

Louisiana Medication Assisted Treatment (MAT) Information

Louisiana Naloxone Information

  • LRS 14:403.10 – Drug-related overdoses; medical assistance; immunity from prosecution
  • LRS 14:403.11 – Administration of opiate antagonists; immunity
  • LRS 40:978.1 – Naloxone; first responder; prescription; administration to third party; limitation of liability
  • LRS 40:978.2 Naloxone; prescription; dispensing; administration by third party; limitation of liability

Louisiana Needle Exchange Programs (NEP) & Syringe Services programs (SSP) Information

  • LRS 40:1024 – Exceptions; defenses; local needle exchanges

Louisiana Neonatal Abstinence Syndrome (NAS), Neonatal Opioid Withdrawal (NOWS) Information

  • LRS 40:1086.11 – Neonatal Abstinence Syndrome: Physician notification
  • LRS 40:1086.12 – Neonatal opiate withdrawal syndrome pilot project
  • LRS 40:2018 – Commission on Perinatal Care and Prevention of Infant Mortality; maternal and infant mortality studies; confidentiality; prohibited disclosure and discovery
  • LRS 40:2159.2 – Substance use disorder facilities treating pregnant women

Louisiana Opioid Litigation Proceeds Information

Louisiana Overdose Prevention Centers (OPC), Supervised Consumption Sites (SCS), Supervised Injection Facilities (SIF) Information

  • NO STATE SPECIFIC INFORMATION IDENTIFIED

Louisiana Overdose Surveillance/Reporting Information

  • LRS 40:978.2.1 – Reporting of opioid-related overdoses
  • LRS 49:219.5 – Advisory Council on Heroin and Opioid Prevention and Education

Louisiana Pain Management Information

Louisiana Pill Press & Counterfeit Medication Information

Louisiana Prescription Drug Drop-Off Information

Louisiana Prescription Drug Importation Information

  • NO STATE SPECIFIC INFORMATION IDENTIFIED

Louisiana Prescription Drug Monitoring Program Information

Louisiana Precursor Chemicals/Including Pseudoephedrine Information

  • LRS 40:962.1.1 – Possession of twelve grams or more of ephedrine, pseudoephedrine, or phenylpropanolamine or their salts, optical isomers, and salts of optical isomers
  • LRS 40:976.1 – Chemical precursor; recordkeeping requirements
  • LRS 40:1049.3 – Restriction on the sale of nonprescription products containing ephedrine, pseudoephedrine, or phenylpropanolamine or their salts, optical isomers, and salts of optical isomers
  • LRS 40:1049.4 – Central computer monitoring system; system requirements
  • LRS 40:1049.8 – Pharmacists, certified pharmacy technician, or pharmacy employee not required to stop sale; may report

Louisiana Prison/Jail Program(s) Information

Louisiana School Programs/Information

  • LRS 17:403 – Section on drug free schools and communities; program; section administrator; counselors
  • LRS 17:436.1 – Administration of medication; definition; conditions; restrictions; exceptions

Louisiana Sober Living Homes/Recovery Residence Information

  • LRS 40:2159.1 – Residential substance use disorder facilities
  • LRS 40:2159.2 – Substance use disorder facilities treating pregnant women

Louisiana Substance Abuse Services Information

  • LRS 17:404 – Establishment of programs of substance abuse
  • LRS 28:52.4 – Admission by relative or legal guardian for substance-related or addictive disorder treatment

Louisiana Telemedicine/Telehealth Information

  • LRS 22:1842 – Telemedicine medical services and telehealth healthcare services statement
  • LRS 22:1843 – Remote patient monitoring services
  • LRS 37:1271 – License to practice medicine or telemedicine required
  • LRS 37:1271.1 – Practice of telemedicine in licensed healthcare facilities
  • LRS 40:1223.1 et seq – Louisiana Telehealth Access Act

Last Updated – 7/24/2024

Please report any broken links to tech@naddi.org

Copyright © 2025 - NADDI. All Rights Reserved.

Disclaimer / Privacy Policy / Copyright Policy

Log in with your credentials

Forgot your details?